GLYCINE-N-FMOC (13C2,15N) is an isotopically labeled glycine derivative bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the amino nitrogen, with the carbonyl carbon and the alpha-carbon enriched in 13C and the nitrogen enriched in 15N. The molecule retains the free carboxylic acid functionality while the amino group is carbamate-protected, and the Fmoc group provides a removable handle for chemoselective incorporation into peptide-building sequences. In synthetic and analytical workflows, it functions as a labeled, protected amino acid intermediate for solid-phase or solution-phase peptide synthesis and as an isotopic tracer for mass spectrometry-based studies of peptide or protein labeling patterns.
CAT No: L-Iso-0289
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More